metformin has been researched along with gastrins in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Garg, SK; Michels, AW; Shah, VN | 1 |
Brønden, A; Christensen, M; Hansen, M; Holst, JJ; Knop, FK; Rehfeld, JF; Rohde, U; Sonne, DP; Toräng, S; Vilsbøll, T | 1 |
Clemmensen, C; DiMarchi, RD; Finan, B; Hofmann, SM; Müller, TD; Tschöp, MH | 1 |
Bozkuş, Y; Demir, CÇ; İyidir, ÖT; Kırnap, N; Mousa, U; Nar, A; Tütüncü, NB | 1 |
2 review(s) available for metformin and gastrins
Article | Year |
---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases.
Topics: Animals; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrins; Gastrointestinal Hormones; Glucagon-Like Peptide 1; Humans; Male; Metabolic Diseases; Metformin; Mice; Molecular Targeted Therapy; Obesity; Prognosis; Risk Assessment; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2019 |
2 trial(s) available for metformin and gastrins
Article | Year |
---|---|
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.
Topics: Adult; Blood Glucose; C-Peptide; Cholecystokinin; Double-Blind Method; Gallbladder; Gallbladder Emptying; Gastrins; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Organ Size; Ultrasonography; Young Adult | 2016 |
Short-Term Effect of Hypergastrinemia Following Esomeprazole Treatment On Well-Controlled Type 2 Diabetes Mellitus: A Prospective Study.
Topics: Aged; Anti-Ulcer Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Esomeprazole; Female; Gastrins; Glycated Hemoglobin; Glycemic Control; Humans; Male; Metformin; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Up-Regulation | 2020 |